Sai Parenteral’s IPO Description – Sai Parenteral’s is a diversified pharmaceutical formulations player with integrated capabilities across research, development, and manufacturing, operating through two core verticals: Branded Generic Formulations and Contract Development and Manufacturing Organisation …

We have conducted a deep analysis of the GSP Crop Science RHP and financial disclosures. While you may see the headline growth and improved margins as a compelling story, our GSP Crop IPO analysis reveals …

We have conducted a deep analysis of the GSP Crop Science RHP and financial disclosures. While you may see the headline growth and improved margins as a compelling story, our GSP Crop IPO analysis reveals …

Speciality Medicines IPO Description – Speciality Medicines is a leading pharmaceutical company engaged in the marketing and distribution of specialty pharmaceutical products, including high-cost oral and injectable medications for complex and chronic medical conditions. The company …

Speciality Medicines IPO Description – Speciality Medicines is a leading pharmaceutical company engaged in the marketing and distribution of specialty pharmaceutical products, including high-cost oral and injectable medications for complex and chronic medical conditions. The company …

Jagsonpal Pharmaceuticals Buyback Record Date is not finalized.  Jagsonpal Pharmaceuticals is a pharmaceutical company engaged in the manufacturing and marketing of branded generic formulations across multiple therapeutic segments. Jagsonpal primarily focuses on the domestic formulations …